Related Experiment Videos
New approaches to specific immunomodulation in transplantation
A I Colovai1, E R Molajoni, R Cortesini
1College of Physicians & Surgeons of Columbia University, Department of Pathology, New York, New York 10032, USA.
International Reviews of Immunology
|January 1, 1996
Summary
The indirect pathway of T cell recognition is key in graft rejection, focusing on specific HLA-DR molecules and peptides. This understanding may lead to targeted therapies to prevent organ transplant rejection.
Area of Science:
- Immunology
- Transplantation immunology
Background:
- T cells recognize foreign MHC antigens directly or indirectly via processed peptides.
- The indirect pathway of allorecognition is crucial in initiating and sustaining graft rejection.
Purpose of the Study:
- To investigate the specific mechanisms of indirect allorecognition in graft rejection.
- To identify potential targets for immune interventions to prevent rejection.
Main Methods:
- Analysis of T cell recognition pathways.
- Investigation of HLA-DR molecule involvement in allopeptide presentation.
- Examination of T cell receptor variable gene usage in alloreactive T cells.
Main Results:
- Indirect recognition is limited to a single peptide determinant of an allogeneic HLA-DR molecule.
- This recognition is restricted by a single self HLA-DR molecule.
- T cells involved show limited T cell receptor variable gene expression.
Conclusions:
- Selective immune interventions targeting the dominant allopeptide presentation may prevent graft rejection.
- Therapeutic strategies like peptide blockade, high-zone tolerance induction, or TCR antagonism show promise.